|
Patent landscape, scope, and claims: |
United States Patent 8,075,872: A Detailed Analysis of Scope and Claims
Introduction to Patent 8,075,872
Patent Overview
Patent 8,075,872, titled "Abuse-proofed dosage form," was granted on December 27, 2011. This patent pertains to a dosage form that is thermoshaped without being extruded and is safeguarded from abuse. The invention aims to prevent the misuse of pharmaceuticals by making them difficult to crush or dissolve, thereby reducing the risk of abuse[4].
Background and Objectives
Background
The background of this patent highlights the need for abuse-proofed dosage forms. Traditional pharmaceutical formulations can be easily manipulated, leading to potential misuse. The objective of this invention is to create a dosage form that is resistant to such manipulations, ensuring safer use of medications[4].
Claims and Scope
Claims Analysis
The patent includes several claims that define the scope of the invention. Key claims include:
- Claim 1: A dosage form that is thermoshaped without being extruded and is safeguarded from abuse[4].
- Claim 2: The dosage form comprising at least one synthetic or natural polymer matrix material[4].
- Claim 3: The dosage form optionally including a liquid component that is dispersed within the matrix material[4].
Patent Landscape
Patent Landscape Analysis
To understand the patent landscape, it is essential to analyze related patents and their expiration dates. Here are some relevant patents:
- U.S. Patent 6,071,970: Expiration date June 6, 2017[2].
- U.S. Patent 7,994,364: Expiration date June 27, 2025[2].
- U.S. Patent 8,114,383: Expiration date October 10, 2024[2].
- U.S. Patent 8,309,060: Expiration date November 20, 2023[2].
Impact on Pharmaceutical Industry
Impact on Pharmaceutical Industry
The invention described in Patent 8,075,872 has significant implications for the pharmaceutical industry. By creating abuse-proofed dosage forms, manufacturers can reduce the risk of drug misuse and ensure safer administration of medications. This innovation aligns with ongoing efforts to develop safer pharmaceuticals[4].
Comparison with Other Abuse-Deterrent Formulations
Comparison with Other Abuse-Deterrent Formulations
Other patents, such as U.S. Patent 8,075,872, focus on developing abuse-deterrent formulations. For instance:
- U.S. Patent 8,078,813: Describes an abuse-deterrent pharmaceutical composition that reduces the likelihood of improper administration of drugs[5].
- U.S. Patent 8,078,813: Uses fatty acids and active agents to deter abuse, making it difficult to crush or dissolve the drug[5].
Legal Status and Expiration Date
Legal Status and Expiration Date
As of the current date (December 19, 2024), U.S. Patent 8,075,872 is expired. The legal status of this patent is expired-lifetime, indicating that it no longer provides exclusive rights to its inventor[4].
Conclusion
Conclusion
In conclusion, U.S. Patent 8,075,872 represents a significant advancement in the development of abuse-proofed dosage forms. By analyzing the claims and scope of this patent, we can understand its impact on the pharmaceutical industry and its place within the broader landscape of abuse-deterrent formulations.
Key Takeaways
- Invention Overview: The patent describes an abuse-proofed dosage form that is thermoshaped without being extruded.
- Claims Analysis: Key claims include the dosage form's composition and its ability to prevent abuse.
- Patent Landscape: Relevant patents include U.S. Patents 6,071,970, 7,994,364, 8,114,383, and 8,309,060.
- Impact on Industry: The invention reduces the risk of drug misuse and ensures safer administration of medications.
- Comparison with Other Formulations: Other patents focus on similar abuse-deterrent formulations using different methods.
FAQs
-
What is the main objective of U.S. Patent 8,075,872?
- The main objective is to create an abuse-proofed dosage form that prevents misuse by making it difficult to crush or dissolve.
-
What are the key claims of this patent?
- Key claims include the dosage form being thermoshaped without being extruded and being safeguarded from abuse.
-
How does this patent impact the pharmaceutical industry?
- It reduces the risk of drug misuse and ensures safer administration of medications.
-
What are some other relevant patents in this field?
- U.S. Patents 6,071,970, 7,994,364, 8,114,383, and 8,309,060 are relevant.
-
Is U.S. Patent 8,075,872 still valid?
- No, it is expired as of December 27, 2011.
Cited Information:
- U.S. Patent 8,075,872 B2 - Abuse-proofed dosage form[4].
- U.S. Patent 6,071,970 - Expiration date June 6, 2017[2].
- U.S. Patent 7,994,364 - Expiration date June 27, 2025[2].
- U.S. Patent 8,114,383 - Expiration date October 10, 2024[2].
- U.S. Patent 8,309,060 - Expiration date November 20, 2023[2].
More… ↓
⤷ Subscribe
|
